Banco BTG Pactual’s Novartis NVS Stock Holding History

Banco BTG Pactual’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-13,280	Closed	-$1.02M	–	65
2017 Q3	$1.02M	Buy	+13,280	New	+$1M	0.42%	24

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Banco BTG Pactual's NVS Position: Q4 2017 in Review

Banco BTG Pactual sold out of Novartis (NVS) in Q4 2017, closing a stake of 13,280 shares — an estimated $1.02M sold.

Banco BTG Pactual first reported a position in NVS in Q3 2017 and held it in 1 quarter. The position peaked at $1.02M in Q3 2017. 1,006 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

Banco BTG Pactual reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
Banco BTG Pactual sold 13,280 Novartis shares in Q4 2017, an estimated $1.02M.
Banco BTG Pactual first reported a position in Novartis in Q3 2017 and held it in 1 quarter.
Banco BTG Pactual's Novartis position peaked at $1.02M in Q3 2017.
1,006 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Banco BTG Pactual's 13F filing for Q4 2017, filed 9 Feb 2018.